Skip to main content
. 2016 Jul 19;5(7):e003642. doi: 10.1161/JAHA.116.003642

Table 2.

Mean Baseline and Change in SAQ Scores, Stratified by Treatment and eGFR

Treatment and eGFR SAQ Domain
Quality of Life Angina Frequency Angina Stability Physical Limitation Treatment Satisfaction
Baseline Score, Mean (SD) Mean (95% CI) Change in Score P Value Baseline Score, Mean (SD) Mean (95% CI) Change in Score P Value Baseline Score, Mean (SD) Mean (95% CI) Change in Score P Value Baseline Score, Mean (SD) Mean (95% CI) Change in Score P Value Baseline Score, Mean (SD) Mean (95% CI) Change in Score P Value
CABG
eGFR ≥90 51.2 (26.2) 22.1 (18.5–25.7) 0.38 78.0 (25.4) 9.5 (6.0–12.9) 0.39 64.0 (31.5) 6.4 (1.1–11.6) 0.32 64.4 (24.2) 16.6 (13.3–19.8) 0.57 88.2 (14.8) −0.3 (−2.7 to 2.2) 0.22
eGFR 60 to 89 54.2 (26.4) 23.1 (20.3–25.9) 77.6 (25.0) 11.1 (8.4–13.8) 62.4 (30.7) 8.5 (4.3–12.6) 63.1 (23.2) 17.2 (14.7–19.8) 87.7 (16.2) 1.6 (−0.3 to 3.6)
eGFR 45 to 59 55.1 (27.1) 24.6 (20.8–28.4) 76.9 (25.9) 12.5 (8.9–16.2) 60.5 (27.7) 8 (2.4–13.6) 60.5 (23.8) 15.6 (12.1–19.0) 87.4 (15.1) 1.7 (−1.0 to 4.3)
eGFR 30 to 44 56.2 (24.8) 22.6 (16.8–28.4) 77.9 (26.9) 13.3 (7.8–18.8) 61.0 (29.2) 13.2 (4.7–21.7) 54.7 (25.2) 18.5 (13.2–23.7) 86 (16.1) 4.3 (0.3–8.3)
eGFR <30 58.2 (28.1) 14.0 (2.3–25.6) 79.1 (26.9) 5.9 (−5.2 to 17.1) 50 (34.4) 20.8 (3.8–27.9) 41.7 (17.4) 19.3 (8.8–29.9) 84.2 (18.6) 1.8 (−6.2 to 9.9)
Overall 53.9 (26.5) 22.8 (20.2–25.4) 77.6 (25.37) 11.3 (8.8–13.8) 62.3 (30.4) 8.4 (4.5–12.2) 62.3 (23.8) 17.4 (15.0–19.8) 87.0 (15.8) 1.5 (−0.3 to 3.3)
PCI
eGFR ≥90 64.4 (24.3) 5.8 (2.9–8.7) 0.51 82.0 (22.2) 3.6 (0.8–6.4) 0.86 76.8 (29.5) −6.2 (−10.4, −1.9) 0.31 76.5 (22.0) 5.7 (3.1–8.3) 0.61 87.5 (15.5) −1.6 (−3.6 to 0.5) 0.83
eGFR 60 to 89 67.3 (23.1) 7.0 (4.3–9.6) 84.2 (21.5) 3.2 (0.7–5.8) 78.7 (27.2) −7.7 (−11.6, −3.8) 75.7 (23.1) 6.1 (3.7–8.5) 89.0 (14.7) −1.8 (−3.7 to 0.0)
eGFR 45 to 59 68.6 (23.2) 7.2 (4.1–10.3) 83.9 (23.0) 2.9 (−0.1 to 5.9) 75 (28.1) −6.0 (−10.6, −1.5) 71.9 (24.1) 5.5 (2.7–8.3) 89.5 (14.1) −1.8 (−4.0 to 0.3)
eGFR 30 to 44 68.8 (23.2) 5.8 (1.5–10.2) 82.8 (24.0) 3.8 (−0.3 to 8.0) 79.0 (27.5) −10.7 (−17.0, −4.3) 63.3 (24.7) 6.8 (2.8–10.7) 88.7 (14.2) −2.7 (−5.7 to 0.3)
eGFR <30 63.7 (26.4) 10.0 (1.4–18.7) 87.2 (19.9) 0.4 (−7.9 to 8.7) 77.3 (26.1) −1.5 (−14.2, 11.2) 56.8 (25.0) 9.8 (2.0–17.7) 91.2 (13.4) −1.8 (−7.8 to 4.2)
Overall 66.8 (23.5) 6.6 (4.0–9.1) 83.6 (22.0) 3.4 (1.0–5.8) 77.8 (27.9) −7.3 (−11.0 to −3.6) 74.9 (23.3) 6.4 (4.1–8.7) 88.7 (14.8) −1.6 (−3.7 to 0.1)
Medicine
eGFR ≥90 60.5 (24.1) 5.4 (2.0–8.8) 0.28 79.6 (22.7) 1.9 (−1.4 to 5.1) 0.43 64.9 (27.0) 0.2 (−4.8 to 5.2) 0.59 72.4 (23.8) 2.7 (−0.4 to 5.8) 0.5 83.4 (18.1) −1.8 (−4.2 to 0.5) 0.58
eGFR 60 to 89 66.2 (23.4) 5.5 (2.8–8.3) 83.1 (21.4) 1.1 (−1.6 to 3.7) 66.5 (26.8) −1.4 (−5.4 to 2.7) 71.7 (23.8) 2.9 (0.4–5.4) 85 (16.9) −1.1 (−3.0 to 0.8)
eGFR 45 to 59 67.9 (23.1) 2.8 (−0.7 to 6.3) 83.9 (20.9) −1.2 (−4.6 to 2.1) 63.9 (25.9) −1.4 (−6.5 to 3.8) 66.9 (24.6) 2.4 (−0.8 to 5.6) 86.3 (15.3) −2.6 (−5.0, −0.1)
eGFR 30 to 44 65.7 (23.3) 4.4 (−0.3 to 9.1) 79.5 (23.4) 1 (−3.4 to 5.5) 60.9 (28.67) −1.9 (−8.8 to 4.9) 62.4 (22.5) 2.8 (−1.4 to 7.1) 85.8 (14.7) −1.8 (−5.0, 1.5)
eGFR <30 62.0 (23.8) 8.9 (1.4–16.3) 82.7 (24.0) −0.1 (−7.2 to 7.0) 70.0 (25.3) −7.9 (−18.8 to 2.9) 54.0 (27..0) 7.5 (0.8–14.2) 85.0 (16.3) −0.3 (−5.4 to 4.8)
Overall 65.3 (23.6) 4.9 (2.4–7.5) 82.3 (21.9) 0.9 (−1.5 to 3.4) 65.5 (26.8) −1.3 (−5.0 to 2.5) 70.0 (24.2) 3.5 (1.2–5.8) 85.0 (16.8) −1.3 (−3.0 to 0.5)

eGFR indicates estimated glomerular filtration rate (mL/min per 1.73m2); SAQ, Seattle Angina Questionnaire.